The Patent Finder
US

Diagnosis of Intra-Uterine Infection by Proteomic Analysis of Cervical-Vaginal Fluids

US 8,068,990 Term ended
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Apr 8, 2026 (Royal Bank of Canada).

Term ended Oct 29, 2026 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed Nov 9, 2006 as application 11/595,221 · Granted Nov 29, 2011
Base term plus 1314 days of patent term adjustment (USPTO delay)
Today
20 years from filing
Term ended Oct 29, 2026
2003 2026
Clock starts
Mar 25, 2003
Term ended
Oct 29, 2026
Granted
Nov 29, 2011
base term patent term adjustment after the term ends fee events Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,314
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 1314 days past its 20-year base term on prosecution delay. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 25, 2003, when application 10/400,005, the earliest non-provisional in its chain, was filed (this one was filed Nov 9, 2006); a parent in its chain could not be resolved (the next row)Mar 25, 2023High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+1314 days, USPTO patent term adjustment recordOct 29, 2026High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderOct 29, 2026Medium confidence

This family

US 7,191,068Term ended
Oct 2023
Oct 2023
Application PCT/US2004/008954PCT application
no patent term
no patent term
Application 11/473,797Abandoned
not computed
not computed
US 8,068,990this patent
Oct 2026
Oct 2026
Application PCT/US2007/084311PCT application
no patent term
no patent term
Application 12/217,687Abandoned
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Mar 14, 2007
Reel 19054, frame 105
Rosenfeld, Ron; Nagalla, Srinivasa; Gravett, Michael S.Proteogenix, Inc.Assignment of Assignor's Interest
Mar 10, 2011
Reel 25931, frame 472
Proteogenix (Assignment for the Benefit of Creditors) LLCHologic, Inc.Assignment of Assignor's Interest
Apr 19, 2011
Reel 26149, frame 524
Proteogenix, Inc.Proteogenix (Assignment for the Benefit of Creditors) LLCAssignment of Assignor's Interest
Aug 1, 2012
Reel 28810, frame 745
Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe IncorporatedGoldman Sachs Bank USASecurity Agreement
Jun 4, 2015
Reel 35820, frame 239
Goldman Sachs Bank USA, as Collateral AgentHologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe IncorporatedSecurity Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentHologic, Inc.Security Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentBiolucent, LLCSecurity Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentCytyc CorporationSecurity Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentCytyc Surgical Products, Limited PartnershipSecurity Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentSuros Surgical Systems, Inc.Security Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentThird Wave Technologies, Inc.Security Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentGen-Probe IncorporatedSecurity Interest Release Reel/Frame 028810/0745
Aug 7, 2015
Reel 36307, frame 199
Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.Bank of America, N.A., as Collateral AgentSecurity Agreement
Nov 9, 2017
Reel 44432, frame 565
Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe IncorporatedGoldman Sachs Bank USACorrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 028810 Frame: 0745. Assignor(S) Hereby Confirms the Security Agreement.
Nov 9, 2017
Reel 44727, frame 529
Goldman Sachs Bank USA, as Collateral AgentHologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe IncorporatedCorrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentHologic, Inc.Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentBiolucent, LLCCorrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentCytyc CorporationCorrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentCytyc Surgical Products, Limited PartnershipCorrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentSuros Surgical Systems, Inc.Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentThird Wave Technologies, Inc.Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentGen-Probe IncorporatedCorrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Apr 8, 2026
Reel 75462, frame 440
Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc.Royal Bank of Canada, as Collateral AgentSecurity Interest
Apr 8, 2026
Reel 75926, frame 339
Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc.Citibank, N.A., as Collateral AgentSecurity Interest
Apr 28, 2026
Reel 75566, frame 39
Bank of America, N.A., as Collateral AgentHologic, Inc., on Its Own Behalf and as Successor-by-Merger to Direct Radiography Corp.; Cytyc Corporation, on Its Own Behalf and as Successor-by-Merger to Biolucent, LLC; Cytyc Surgical Products, LLC, as Successor-by-Conversion to Cytyc Surgical Products, Limited Partnership; Gen-Probe Incorporated, on Its Own Behalf and as Successor-by-Merger to Third Wave Technologies, Inc.; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited